Skip to main content
icon for A avaliação de Anduril atingirá __ até 31 de julho?

A avaliação de Anduril atingirá __ até 31 de julho?

icon for A avaliação de Anduril atingirá __ até 31 de julho?

A avaliação de Anduril atingirá __ até 31 de julho?

Current Valuation:$90.67B
+70.42%
Powered byNasdaq Private Markets

$28,673 Vol.

1 ago 2026
Polymarket
Current Valuation:$90.67B
+70.42%
Powered byNasdaq Private Markets

$28,673 Vol.

Polymarket

↑US$200B

$2,840 Vol.

3%

↑$150B

$4,450 Vol.

<1%

↑US$125B

$913 Vol.

3%

↑$110B

$3,212 Vol.

12%

↓US$90B

$2,405 Vol.

22%

↓$85B

$9,388 Vol.

9%

↓US$80B

$365 Vol.

2%

↓US$75B

$1,893 Vol.

5%

↓$70B

$1,837 Vol.

3%

This market will resolve to "Yes" if Anduril's private market valuation, as measured by the NPM Price reported by Nasdaq Private Market, LLC (NPM) for any date between market creation and July 31, 2026, reaches or exceeds the listed amount. Otherwise, this market will resolve to "No". NPM Prices are published for trading days only and are updated once daily at 1:00 PM ET on the following calendar day. If NPM has not published relevant data for all business dates in the specified period by 1:00 PM ET on August 1, 2026, this market may remain open until 11:59 PM ET on August 4, 2026. If no further data is released by that time, the market will resolve according to the data available. If NPM ceases publishing relevant data prior to the end of the specified period, this market will resolve based on the NPM data published for the period prior to the cessation of coverage, as well as any applicable public market capitalization data following an IPO or direct listing. If the company completes an IPO or direct listing before the end of the specified period, this market will consider, in addition to the relevant NPM valuations published between market creation and the IPO or direct listing date, the valuation implied by the official IPO or direct listing price, and the company's public market capitalization between the IPO or direct listing date and the end of the specified period. Public market capitalization will be determined using the highest/lowest official regular-hours trading price published for the company's primary listed common equity on its primary exchange for any trading day during the specified period, multiplied by the company's total outstanding common shares at the relevant time. If the listed company merges with or acquires another entity and remains the parent company, no change to resolution methodology applies. If the listed company is acquired, merges into another entity and is no longer the surviving parent company, or otherwise ceases to exist as an independent entity prior to the end of the period, only NPM valuations and applicable public market capitalizations achieved prior to completion of the transaction will be considered for resolution. No transaction, acquisition, or merger consideration will be considered for resolution. The resolution source for this market is NPM data published here: (https://fe.secondmarket.com/companies/company-c62b8140-fdeb-428d-a9a6-d04eb3b24b49/data). The resolution source for any period following an IPO, direct listing, or relevant corporate action, will be official exchange trading data and publicly reported share counts. Revisions to previously published NPM data made after their initial release will not be considered, unless made to correct clearly erroneous data.Anduril’s May 2026 Series H round of $5 billion, which doubled its post-money valuation to $61 billion, remains the dominant anchor for trader sentiment ahead of the July 31 resolution. That financing, led by Thrive Capital and Andreessen Horowitz, reflects robust defense-tech demand and positions the company well ahead of any potential IPO, but the compressed timeline leaves little room for additional funding rounds or material revenue disclosures that could support a higher mark. With no reported valuation updates or major contract announcements since mid-May, market-implied odds hinge on whether secondary-share trading or new investor interest can push perceived value beyond the latest primary round. Traders are also monitoring broader defense-budget signals and comparable private-market multiples for context on near-term upside.

This market will resolve to "Yes" if Anduril's private market valuation, as measured by the NPM Price reported by Nasdaq Private Market, LLC (NPM) for any date between market creation and July 31, 2026, reaches or exceeds the listed amount. Otherwise, this market will resolve to "No".

NPM Prices are published for trading days only and are updated once daily at 1:00 PM ET on the following calendar day.

If NPM has not published relevant data for all business dates in the specified period by 1:00 PM ET on August 1, 2026, this market may remain open until 11:59 PM ET on August 4, 2026. If no further data is released by that time, the market will resolve according to the data available.

If NPM ceases publishing relevant data prior to the end of the specified period, this market will resolve based on the NPM data published for the period prior to the cessation of coverage, as well as any applicable public market capitalization data following an IPO or direct listing.

If the company completes an IPO or direct listing before the end of the specified period, this market will consider, in addition to the relevant NPM valuations published between market creation and the IPO or direct listing date, the valuation implied by the official IPO or direct listing price, and the company's public market capitalization between the IPO or direct listing date and the end of the specified period.

Public market capitalization will be determined using the highest/lowest official regular-hours trading price published for the company's primary listed common equity on its primary exchange for any trading day during the specified period, multiplied by the company's total outstanding common shares at the relevant time.

If the listed company merges with or acquires another entity and remains the parent company, no change to resolution methodology applies.

If the listed company is acquired, merges into another entity and is no longer the surviving parent company, or otherwise ceases to exist as an independent entity prior to the end of the period, only NPM valuations and applicable public market capitalizations achieved prior to completion of the transaction will be considered for resolution. No transaction, acquisition, or merger consideration will be considered for resolution.

The resolution source for this market is NPM data published here: (https://fe.secondmarket.com/companies/company-c62b8140-fdeb-428d-a9a6-d04eb3b24b49/data). The resolution source for any period following an IPO, direct listing, or relevant corporate action, will be official exchange trading data and publicly reported share counts.

Revisions to previously published NPM data made after their initial release will not be considered, unless made to correct clearly erroneous data.
Volume
$28,673
Data de Término
1 ago 2026
Mercado Aberto
Jun 29, 2026, 8:07 PM ET
This market will resolve to "Yes" if Anduril's private market valuation, as measured by the NPM Price reported by Nasdaq Private Market, LLC (NPM) for any date between market creation and July 31, 2026, reaches or exceeds the listed amount. Otherwise, this market will resolve to "No". NPM Prices are published for trading days only and are updated once daily at 1:00 PM ET on the following calendar day. If NPM has not published relevant data for all business dates in the specified period by 1:00 PM ET on August 1, 2026, this market may remain open until 11:59 PM ET on August 4, 2026. If no further data is released by that time, the market will resolve according to the data available. If NPM ceases publishing relevant data prior to the end of the specified period, this market will resolve based on the NPM data published for the period prior to the cessation of coverage, as well as any applicable public market capitalization data following an IPO or direct listing. If the company completes an IPO or direct listing before the end of the specified period, this market will consider, in addition to the relevant NPM valuations published between market creation and the IPO or direct listing date, the valuation implied by the official IPO or direct listing price, and the company's public market capitalization between the IPO or direct listing date and the end of the specified period. Public market capitalization will be determined using the highest/lowest official regular-hours trading price published for the company's primary listed common equity on its primary exchange for any trading day during the specified period, multiplied by the company's total outstanding common shares at the relevant time. If the listed company merges with or acquires another entity and remains the parent company, no change to resolution methodology applies. If the listed company is acquired, merges into another entity and is no longer the surviving parent company, or otherwise ceases to exist as an independent entity prior to the end of the period, only NPM valuations and applicable public market capitalizations achieved prior to completion of the transaction will be considered for resolution. No transaction, acquisition, or merger consideration will be considered for resolution. The resolution source for this market is NPM data published here: (https://fe.secondmarket.com/companies/company-c62b8140-fdeb-428d-a9a6-d04eb3b24b49/data). The resolution source for any period following an IPO, direct listing, or relevant corporate action, will be official exchange trading data and publicly reported share counts. Revisions to previously published NPM data made after their initial release will not be considered, unless made to correct clearly erroneous data.
This market will resolve to "Yes" if Anduril's private market valuation, as measured by the NPM Price reported by Nasdaq Private Market, LLC (NPM) for any date between market creation and July 31, 2026, reaches or exceeds the listed amount. Otherwise, this market will resolve to "No". NPM Prices are published for trading days only and are updated once daily at 1:00 PM ET on the following calendar day. If NPM has not published relevant data for all business dates in the specified period by 1:00 PM ET on August 1, 2026, this market may remain open until 11:59 PM ET on August 4, 2026. If no further data is released by that time, the market will resolve according to the data available. If NPM ceases publishing relevant data prior to the end of the specified period, this market will resolve based on the NPM data published for the period prior to the cessation of coverage, as well as any applicable public market capitalization data following an IPO or direct listing. If the company completes an IPO or direct listing before the end of the specified period, this market will consider, in addition to the relevant NPM valuations published between market creation and the IPO or direct listing date, the valuation implied by the official IPO or direct listing price, and the company's public market capitalization between the IPO or direct listing date and the end of the specified period. Public market capitalization will be determined using the highest/lowest official regular-hours trading price published for the company's primary listed common equity on its primary exchange for any trading day during the specified period, multiplied by the company's total outstanding common shares at the relevant time. If the listed company merges with or acquires another entity and remains the parent company, no change to resolution methodology applies. If the listed company is acquired, merges into another entity and is no longer the surviving parent company, or otherwise ceases to exist as an independent entity prior to the end of the period, only NPM valuations and applicable public market capitalizations achieved prior to completion of the transaction will be considered for resolution. No transaction, acquisition, or merger consideration will be considered for resolution. The resolution source for this market is NPM data published here: (https://fe.secondmarket.com/companies/company-c62b8140-fdeb-428d-a9a6-d04eb3b24b49/data). The resolution source for any period following an IPO, direct listing, or relevant corporate action, will be official exchange trading data and publicly reported share counts. Revisions to previously published NPM data made after their initial release will not be considered, unless made to correct clearly erroneous data.Anduril’s May 2026 Series H round of $5 billion, which doubled its post-money valuation to $61 billion, remains the dominant anchor for trader sentiment ahead of the July 31 resolution. That financing, led by Thrive Capital and Andreessen Horowitz, reflects robust defense-tech demand and positions the company well ahead of any potential IPO, but the compressed timeline leaves little room for additional funding rounds or material revenue disclosures that could support a higher mark. With no reported valuation updates or major contract announcements since mid-May, market-implied odds hinge on whether secondary-share trading or new investor interest can push perceived value beyond the latest primary round. Traders are also monitoring broader defense-budget signals and comparable private-market multiples for context on near-term upside.

This market will resolve to "Yes" if Anduril's private market valuation, as measured by the NPM Price reported by Nasdaq Private Market, LLC (NPM) for any date between market creation and July 31, 2026, reaches or exceeds the listed amount. Otherwise, this market will resolve to "No".

NPM Prices are published for trading days only and are updated once daily at 1:00 PM ET on the following calendar day.

If NPM has not published relevant data for all business dates in the specified period by 1:00 PM ET on August 1, 2026, this market may remain open until 11:59 PM ET on August 4, 2026. If no further data is released by that time, the market will resolve according to the data available.

If NPM ceases publishing relevant data prior to the end of the specified period, this market will resolve based on the NPM data published for the period prior to the cessation of coverage, as well as any applicable public market capitalization data following an IPO or direct listing.

If the company completes an IPO or direct listing before the end of the specified period, this market will consider, in addition to the relevant NPM valuations published between market creation and the IPO or direct listing date, the valuation implied by the official IPO or direct listing price, and the company's public market capitalization between the IPO or direct listing date and the end of the specified period.

Public market capitalization will be determined using the highest/lowest official regular-hours trading price published for the company's primary listed common equity on its primary exchange for any trading day during the specified period, multiplied by the company's total outstanding common shares at the relevant time.

If the listed company merges with or acquires another entity and remains the parent company, no change to resolution methodology applies.

If the listed company is acquired, merges into another entity and is no longer the surviving parent company, or otherwise ceases to exist as an independent entity prior to the end of the period, only NPM valuations and applicable public market capitalizations achieved prior to completion of the transaction will be considered for resolution. No transaction, acquisition, or merger consideration will be considered for resolution.

The resolution source for this market is NPM data published here: (https://fe.secondmarket.com/companies/company-c62b8140-fdeb-428d-a9a6-d04eb3b24b49/data). The resolution source for any period following an IPO, direct listing, or relevant corporate action, will be official exchange trading data and publicly reported share counts.

Revisions to previously published NPM data made after their initial release will not be considered, unless made to correct clearly erroneous data.
Volume
$28,673
Data de Término
1 ago 2026
Mercado Aberto
Jun 29, 2026, 8:07 PM ET
This market will resolve to "Yes" if Anduril's private market valuation, as measured by the NPM Price reported by Nasdaq Private Market, LLC (NPM) for any date between market creation and July 31, 2026, reaches or exceeds the listed amount. Otherwise, this market will resolve to "No". NPM Prices are published for trading days only and are updated once daily at 1:00 PM ET on the following calendar day. If NPM has not published relevant data for all business dates in the specified period by 1:00 PM ET on August 1, 2026, this market may remain open until 11:59 PM ET on August 4, 2026. If no further data is released by that time, the market will resolve according to the data available. If NPM ceases publishing relevant data prior to the end of the specified period, this market will resolve based on the NPM data published for the period prior to the cessation of coverage, as well as any applicable public market capitalization data following an IPO or direct listing. If the company completes an IPO or direct listing before the end of the specified period, this market will consider, in addition to the relevant NPM valuations published between market creation and the IPO or direct listing date, the valuation implied by the official IPO or direct listing price, and the company's public market capitalization between the IPO or direct listing date and the end of the specified period. Public market capitalization will be determined using the highest/lowest official regular-hours trading price published for the company's primary listed common equity on its primary exchange for any trading day during the specified period, multiplied by the company's total outstanding common shares at the relevant time. If the listed company merges with or acquires another entity and remains the parent company, no change to resolution methodology applies. If the listed company is acquired, merges into another entity and is no longer the surviving parent company, or otherwise ceases to exist as an independent entity prior to the end of the period, only NPM valuations and applicable public market capitalizations achieved prior to completion of the transaction will be considered for resolution. No transaction, acquisition, or merger consideration will be considered for resolution. The resolution source for this market is NPM data published here: (https://fe.secondmarket.com/companies/company-c62b8140-fdeb-428d-a9a6-d04eb3b24b49/data). The resolution source for any period following an IPO, direct listing, or relevant corporate action, will be official exchange trading data and publicly reported share counts. Revisions to previously published NPM data made after their initial release will not be considered, unless made to correct clearly erroneous data.

Cuidado com os links externos.

Frequently Asked Questions

"A avaliação de Anduril atingirá __ até 31 de julho?" is a prediction market on Polymarket with 10 possible outcomes where traders buy and sell shares based on what they believe will happen. The current leading outcome is "↑$100B" at 100%, followed by "↓US$90B" at 22%. Prices reflect real-time crowd-sourced probabilities. For example, a share priced at 100¢ implies that the market collectively assigns a 100% chance to that outcome. These odds shift continuously as traders react to new developments and information. Shares in the correct outcome are redeemable for $1 each upon market resolution.

As of today, "A avaliação de Anduril atingirá __ até 31 de julho?" has generated $28.7K in total trading volume since the market launched on Jun 29, 2026. This level of trading activity reflects strong engagement from the Polymarket community and helps ensure that the current odds are informed by a deep pool of market participants. You can track live price movements and trade on any outcome directly on this page.

To trade on "A avaliação de Anduril atingirá __ até 31 de julho?," browse the 10 available outcomes listed on this page. Each outcome displays a current price representing the market's implied probability. To take a position, select the outcome you believe is most likely, choose "Yes" to trade in favor of it or "No" to trade against it, enter your amount, and click "Trade." If your chosen outcome is correct when the market resolves, your "Yes" shares pay out $1 each. If it's incorrect, they pay out $0. You can also sell your shares at any time before resolution if you want to lock in a profit or cut a loss.

The current frontrunner for "A avaliação de Anduril atingirá __ até 31 de julho?" is "↑$100B" at 100%, meaning the market assigns a 100% chance to that outcome. The next closest outcome is "↓US$90B" at 22%. These odds update in real-time as traders buy and sell shares, so they reflect the latest collective view of what's most likely to happen. Check back frequently or bookmark this page to follow how the odds shift as new information emerges.

The resolution rules for "A avaliação de Anduril atingirá __ até 31 de julho?" define exactly what needs to happen for each outcome to be declared a winner — including the official data sources used to determine the result. You can review the complete resolution criteria in the "Rules" section on this page above the comments. We recommend reading the rules carefully before trading, as they specify the precise conditions, edge cases, and sources that govern how this market is settled.